Indian Journal of Urology Users online:828  
IJU
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others

REVIEW ARTICLE

Chemotherapy options in castration-resistant prostate cancer

Teply Benjamin A, Hauke Ralph J

Year : 2016| Volume: 32| Issue : 4 | Page no: 262-270

   This article has been cited by
 
1 The evolving landscape of PARP inhibitors in castration-resistant prostate cancer: a spotlight on treatment combinations
Benjamin A. Teply, Emmanuel S. Antonarakis
Expert Review of Clinical Pharmacology. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Inhibition of Mps1 kinase enhances taxanes efficacy in castration resistant prostate cancer
Sadia Sarwar, Viacheslav M. Morozov, Hamsa Purayil, Yehia Daaka, Alexander M. Ishov
Cell Death & Disease. 2022; 13(10)
[Pubmed]  [Google Scholar] [DOI]
3 STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell population
Giacomo Canesin, Valentina Maggio, Macarena Palominos, Anna Stiehm, Hector R. Contreras, Enrique A. Castellón, Juan Morote, Rosanna Paciucci, Norman J. Maitland, Anders Bjartell, Rebecka Hellsten
Scientific Reports. 2020; 10(1)
[Pubmed]  [Google Scholar] [DOI]
4 Sildenafil Potentiates the Therapeutic Efficacy of Docetaxel in Advanced Prostate Cancer by Stimulating NO-cGMP Signaling
Sakthivel Muniyan, Satyanarayana Rachagani, Seema Parte, Sushanta Halder, Parthasarathy Seshacharyulu, Prakash Kshirsagar, Jawed A. Siddiqui, Raghupathy Vengoji, Sanchita Rauth, Ridwan Islam, Kavita Mallya, Kaustubh Datta, Lei Xi, Anindita Das, Benjamin A. Teply, Rakesh C. Kukreja, Surinder K. Batra
Clinical Cancer Research. 2020; 26(21): 5720
[Pubmed]  [Google Scholar] [DOI]
5 Aurora B Kinase Promotes CHIP-Dependent Degradation of HIF1a in Prostate Cancer Cells
Kuntal Biswas, Sukumar Sarkar, Neveen Said, David L. Brautigan, James M. Larner
Molecular Cancer Therapeutics. 2020; 19(4): 1008
[Pubmed]  [Google Scholar] [DOI]
6 Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer
Chaojiang Chen, Zhiduan Cai, Yangjia Zhuo, Ming Xi, Zhuoyuan Lin, Funeng Jiang, Zezhen Liu, Yueping Wan, Yu Zheng, Jianxin Li, Xing Zhou, Jianguo Zhu, Weide Zhong
BMC Cancer. 2020; 20(1)
[Pubmed]  [Google Scholar] [DOI]
7 Improving adenoviral vectors and strategies for prostate cancer gene therapy
Rodrigo Esaki Tamura, Igor Vieira de Luna, Marlous Gomes Lana, Bryan E Strauss
Clinics. 2018; 73: e476s
[Pubmed]  [Google Scholar] [DOI]

 

Read this article
Fosfocin